Market Tracker

07/29 6:05pm ET

Seattle Genetics Inc (NASDAQ:SGEN)

During the Trading Day
35.16 +0.76 / +2.21%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
35.24 +0.08 / +0.23%
 
Volume: 2.9K

Today’s Trading

Previous close34.40
Today’s open34.68
Day’s range34.51 - 35.63
Volume674,407
Average volume (3 months)1,081,800
Market cap$4.2B
Dividend yield--
Data as of 4:00pm ET, 07/29/2014

Growth & Valuation

Earnings growth (last year)-10.87%
Earnings growth (this year)-77.81%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+27.73%
P/E ratioNM
Price/Sales18.01
Price/Book18.32

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc-1.51-2.08%
UTHRUnited Therapeutics ...+7.36+8.10%
ICPTIntercept Pharmaceut...+10.15+4.53%
OPKOPKO Health Inc+0.12+1.34%
Data as of 4:02pm ET, 07/29/2014

Financials

Next reporting dateAugust 1, 2014
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$269.3M
Annual profit (last year)-$62.5M
Net profit margin-23.22%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer &
Secretary
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts